{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-084332","form_type":"8-K","ticker":"NVCT","cik":"0001875558","company_name":"Nuvectis Pharma, Inc.","filed_at":"2022-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.574393+00:00","generated_at":"2026-06-24T07:04:13.593499+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuvectis Pharma raises ~$15.9M in private placement of common stock and warrants","bullets":["Gross proceeds $15.9M from sale of 1,924,689 shares or pre-funded warrants at $8.25 per share plus preferred investment options.","Preferred investment options exercisable at $9.65, lockout 6 months, term 3.5 years.","H.C. Wainwright acted as placement agent with 7% cash fee plus 115,481 placement agent warrants at $10.3125.","Net proceeds intended for working capital and general corporate purposes.","Closing expected July 29, 2022, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-084332","json":"https://secwatch.observer/filing/0001104659-22-084332.json","markdown":"https://secwatch.observer/filing/0001104659-22-084332.md","text":"https://secwatch.observer/filing/0001104659-22-084332.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/0001104659-22-084332-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/tm2222131d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:04:13.593499+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}